CORC

浏览/检索结果: 共39条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
The origin of cap carbonate after the Ediacaran glaciations 期刊论文
GLOBAL AND PLANETARY CHANGE, 2023, 卷号: 226, 页码: 18
作者:  Wang, Ruimin;  Xing, Chaochao;  Wen, Bin;  Wang, Xubin;  Liu, Kunwei
收藏  |  浏览/下载:8/0  |  提交时间:2023/10/09
Efficacy and safety of everolimus in combination with trastuzumab and paclitaxel in Asian patients with HER2+advanced breast cancer in BOLERO-1 期刊论文
BREAST CANCER RESEARCH, 2017, 卷号: 19
作者:  Toi, Masakazu;  Shao, Zhimin;  Hurvitz, Sara;  Tseng, Ling-Ming;  Zhang, Qingyuan
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/05
Danggui Buxue Decoction, a Classical Formula of Traditional Chinese Medicine, Fails to Prevent Myelosuppression in Breast Cancer Patients Treated With Adjuvant Chemotherapy: A Prospective Study 期刊论文
INTEGRATIVE CANCER THERAPIES, 2017, 卷号: 16, 期号: 3
作者:  Hong, Jin;  Chen, Xiaosong;  Huang, Jiahui;  Li, Chunqing;  Zhong, Li
收藏  |  浏览/下载:8/0  |  提交时间:2019/12/05
Efficacy and safety of everolimus in combination with trastuzumab and paclitaxel in Asian patients with HER2+advanced breast cancer in BOLERO-1 期刊论文
2017, 卷号: 19, 期号: 1, 页码: 47
作者:  Toi Masakazu;  Shao Zhimin;  Hurvitz Sara;  Tseng Ling-Ming;  Zhang Qingyuan
收藏  |  浏览/下载:3/0  |  提交时间:2020/01/04
Fulvestrant 500 mg vs 250 mg in postmenopausal women with estrogen receptor-positive advanced breast cancer: a randomized, double-blind registrational trial in China 期刊论文
ONCOTARGET, 2016, 卷号: 7, 期号: 35
作者:  Zhang, Qingyuan;  Shao, Zhimin;  Shen, Kunwei;  Li, Li;  Feng, Jifeng
收藏  |  浏览/下载:64/0  |  提交时间:2019/12/05
A multicenter, randomized, controlled, phase Ⅲ clinical study of PEG-rhG-CSF for preventing chemotherapy-induced neutropenia in patients with breast cancer and non-small cell lung cancer]. 期刊论文
Zhonghua zhong liu za zhi [Chinese journal of oncology], 2016, 卷号: 38, 页码: 23-7
作者:  Xu Binghe;  Tian Fuguo;  Yu Jingrui;  Song Yanqiu;  Shi Jianhua
收藏  |  浏览/下载:15/0  |  提交时间:2019/11/26
Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab treatment (LUX-Breast 1): an open-label, randomised, phase 3 trial 期刊论文
LANCET ONCOLOGY, 2016, 卷号: 17, 期号: 3
作者:  Harbeck, Nadia;  Huang, Chiun-Sheng;  Hurvitz, Sara;  Yeh, Dah-Cherng;  Shao, Zhimin
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/06
Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab treatment (LUX-Breast 1): an open-label, randomised, phase 3 trial 期刊论文
2016, 卷号: 17, 期号: 3, 页码: 357-366
作者:  Harbeck, Nadia;  Huang, Chiun-Sheng;  Hurvitz, Sara;  Yeh, Dah-Cherng;  Shao, Zhimin
收藏  |  浏览/下载:1/0  |  提交时间:2020/01/04
Fulvestrant 500 mg vs 250 mg in postmenopausal women with estrogen receptor-positive advanced breast cancer: a randomized, double-blind registrational trial in China 期刊论文
2016, 卷号: 7, 期号: 35, 页码: 57301-57309
作者:  Zhang, Qingyuan;  Shao, Zhimin;  Shen, Kunwei;  Li, Li;  Feng, Jifeng
收藏  |  浏览/下载:59/0  |  提交时间:2020/01/04
A multicenter, randomized, controlled, phase Ⅲ clinical study of PEG-rhG-CSF for preventing chemotherapy-induced neutropenia in patients with breast cancer and non-small cell lung cancer 期刊论文
2016, 卷号: 38, 期号: 1, 页码: 23-7
作者:  Xu Binghe;  Tian Fuguo;  Yu Jingrui;  Song Yanqiu;  Shi Jianhua
收藏  |  浏览/下载:4/0  |  提交时间:2020/01/04


©版权所有 ©2017 CSpace - Powered by CSpace